PUBLISHER: Grand View Research | PRODUCT CODE: 1679433
PUBLISHER: Grand View Research | PRODUCT CODE: 1679433
The global vitamin K2 market size was estimated at USD 292.4 million in 2024 and is projected to grow at a CAGR of 13.5% from 2025 to 2030. Increasing consumer awareness of the health benefits of Vitamin K2, along with demographic factors such as an aging population, changing dietary preferences towards functional foods, and ongoing research validating its therapeutic properties, are key drivers contributing to the growth of the vitamin K2 industry.
Growing consumer awareness of the health benefits of vitamins is a major market driver. Known for its positive effects on bone health, cardiovascular health, and overall well-being, vitamin K2 is gaining attention as more people focus on maintaining good health and preventing chronic diseases. As a result, the demand for vitamin K2 supplements is expected to rise.
In April 2023, Petrovax Pharm, a prominent player in Russia's biotech sector, introduced SunDevit to the Russian market. This innovative complex, featuring a combination of vitamins D3 and K2, was specifically designed to enhance immune function and support muscle, bone, and joint health.
Rising rates of osteoporosis and cardiovascular diseases are further boosting the demand for vitamin K2 products. Vitamin K2 plays a crucial role in bone health by helping direct calcium to the bones, reducing fracture risks. In addition, research shows it can prevent arterial calcification and lower heart disease risk. With an aging population and increasing cases of these conditions, interest in vitamin K2 supplements continues to grow. A study published in February 2024 found that vitamin K2 significantly reduced weight, abdominal fat, and liver fat in mice on a high-fat diet, highlighting its protective role against non-alcoholic fatty liver disease (NAFLD).
The vitamin K2 industry's growth is also driven by companies expanding their product offerings. Manufacturers create innovative formulations and delivery methods to meet diverse consumer preferences and improve product effectiveness. New formats like capsules, tablets, soft gels, liquids, and combinations with other supplements are expected to further propel demand in the nutraceutical industry. In January 2021, MENADIONA launched a new vitamin K2 MK-7 grade for nutraceutical use, adhering to US Pharmacopeia standards for purity. This expansion complements their existing vitamin K2 MK-4 offerings, strengthening their market presence.
Government agencies worldwide increasingly recognize the importance of preventive healthcare through nutrition and dietary supplements, leading to favorable regulatory frameworks that encourage innovation and quality assurance in vitamin K2 production. Moreover, ongoing scientific research continues to uncover new therapeutic applications of vitamin K2 beyond bone and heart health, creating new opportunities for market growth. For example, an October 2023 study in Food & Function revealed that vitamin K2 supplements help regulate fasting blood sugar and insulin resistance, potentially lowering the risk of type 2 diabetes mellitus (T2DM).
Global Vitamin K2 Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global vitamin K2 market report based on product, dosage form, source, indication, application, distribution channel, and region.